There are a myriad of transcutaneous drug delivery techniques and systems already out there including a nifty silicon device with micro "needles". Unless this device has a compelling advantage, it seems a better vehicle for fleecing investors.
This interesting article raises several questions.
1/ The photograph makes the patch appear to be about 7 inches long. Is it really that big?
2/ The article mentions that consumers would expect to pay less than $10 and that reimbursement agencies expect to pay between $35 and $83. Should the article have said that reimbursement agencies see this technology replacing injections which currently cost $35 and $83?
3/ Migraines have historically been difficult to treat with drugs. How effective is this system compared with current treatments? Is this patch simply a superior delivery system for the same drug as current patch technologies?
Blog That A-Ha Moment Larry Desjardin 8 comments Have you ever had an a-ha moment? Sure, you have. The Merriam-Webster dictionary defines it as "a moment of sudden realization, inspiration, insight, recognition, or ...